1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Summary of clinical variables in the training cohort
Survival Groups Poor (OS ≤ 11 mo) Medium (11 < OS < 17 mo) Good (OS ≥ 17 mo) Total No. 152 38 63 Median age (yr) 69.0 57.2 59.5 % Male 61.2 60.5 57.1 Median survival (mo) 4.1 14.1 21.2 Mean survival (mo) 4.8 14.0 26.3 Mean CEL volume (cm3) 34.1 34.0 28.9 STR/GTR/biopsy only (No.) 53/13/86 17/8/13 17/36/10
Note:—STR indicates subtotal resection; GTR, gross total resection.